[ { "@graph" : [ { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#pubinfo" } ] } ], "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#Head" }, { "@graph" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_5844", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#association", "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_5844" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "https://identifiers.org/drugbank:DB00445" } ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "\"ELLENCE is contraindicated in patients with: Severe myocardial insufficiency [see Warnings and Precautions (5.1) Recent myocardial infarction or severe arrhythmias, or previous treatment with maximum cumulative dose of anthracyclines [see Warnings and Precautions (5.1) Severe persistent drug-induced myelosuppression [see Warnings and Precautions (5.4) Severe hepatic impairment (defined as Child-Pugh Class C or serum bilirubin level greater than 5 mg/dL) [see Warnings and Precautions (5.5) Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones [see Adverse Reactions (6.1) Severe myocardial insufficiency ( 4 Recent myocardial infarction ( 4 Severe persistent drug-induced myelosuppression ( 4 Severe hepatic impairment ( 4 Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones ( 4\"" } ], "https://w3id.org/biolink/vocab/provided_by" : [ { "@id" : "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/relation" : [ { "@id" : "https://schema.org/MedicalContraindication" } ] }, { "@id" : "https://identifiers.org/drugbank:DB00445", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Drug" } ] } ], "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#assertion", "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ] } ], "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg", "http://purl.org/dc/terms/created" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2021-08-25T13:53:02.725+02:00" } ], "http://purl.org/dc/terms/creator" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ { "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ { "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ { "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "GBGUgZEZXyxy3omh1cr3zgocpD5dRa4SjR0hHTMC216qt/42JKR3E2VPDKFnMWluW2eRSHG+jfjj9MeJUxKFGuGXvB5UUlvvtaKwJCiBp/J00qGsFiO0ZBU9VNlYBv+7XNwsBFji0Cw/oEq4lSn5q99oSB6wrNyniYvMGB9ILrc=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg" } ] } ], "@id" : "http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#pubinfo" } ]